Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H16N4O2 |
InChIKeyORKOHXAJFGRZCL-LCYFTJDESA-N |
CAS Registry1311143-71-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 31 May 2011 |